Chronic Disease Drugs are Big Business, Antibiotics are Not

By HANS DUVEFELT, MD

I have noticed several articles describing how antibiotic development has bankrupted some pharmaceutical companies because there isn’t enough potential profit in a ten day course to treat multi-resistant superbug infections.

Chronic disease treatments, on the other hand, appear to be extremely profitable. A single month’s treatment with the newer diabetes drugs, COPD inhalers or blood thinners costs over $500, which means well over $50,000 over an effective ten year patent for each one of an ever increasing number of chronically ill patients.

Imagine if the same bureaucratic processes insurance companies have created for chronic disease drug coverage existed (I don’t know if they do) for acute prescriptions of superbug antibiotics: It’s Friday afternoon and a septic patient’s culture comes back indicating that the only drug that would work is an expensive one that requires a Prior Authorization. Patients would die and the insurance companies would be better off if time ran out in such bureaucratic battles for survival.

Suddenly it’s perfectly clear: There is endless profit potential for countless corporations in America’s chronic disease epidemic and it is in their interest that people with chronic disease stay as sick as possible without dying from their disease. Why risk research money on acute disease when there is no continuing revenue stream to look forward to?

If people did all the things we know could improve their health, pharmaceutical companies, insurance companies, pharmacy benefit managers and many others would go out of business, just like shopping malls and print media companies.

Where are the disrupters in healthcare? Will the perverse motives of the sick care industry create a public uproar? Will the old system someday finally crumble?

Now, I’m just a country doctor but I’m starting to wonder if a system like the one we have can really continue to function much longer.

Happy New Year, American Healthcare.

Hans Duvefelt is a Swedish-born rural Family Physician in Maine. This post originally appeared on his blog, A Country Doctor Writes, here.

The post Chronic Disease Drugs are Big Business, Antibiotics are Not appeared first on The Health Care Blog.

Chronic Disease Drugs are Big Business, Antibiotics are Not published first on https://lynxbrands.blogspot.com/

Author: Floydneill

I am an Internet entrepreneur, martial artist and motivational coach, with a goal to help as many people as possible gain financial and time freedom. Time is our most precious asset, as it is one asset we can never get back. Many of us spend our entire lives doing things we hate doing, but must do, in order to survive. Working jobs we don't like, for a boss we can't stand. Getting paid just enough not to quit, and working just hard enough not to get fired. Created debt we can't get out of, because we aren't making enough to cover it, let alone making enough to live on. My goal is to help you change all that. One of my greatest passions is to teach people how to earn a living via the Internet. There is an exact science to this, and once you learn what that is, you become unstoppable.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s